Tranexamic Acid and Bevacizumab in Hereditary Hemorrhagic Telangiectasia Patients Presenting With Epistaxis

被引：0
作者：
Lacout, Alexis [1 ]
Marcy, Pierre-Yves [2 ]
El Hajjam, Mostafa [3 ]
Lacombe, Pascal [3 ]
机构：
[1] Ctr Imagerie Med, Aurillac, France
[2] Francois Baclesse Canc Res Inst, Radiodiagnost Dept, Caen, France
[3] Hop Ambroise Pare, AP HP, Serv Radiol, Boulogne Billancourt, France
来源：
CUTIS | 2013年 / 91卷 / 04期
关键词：
MUTATION; HHT;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 14 条
  • [1] Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler disease)
    Cottin, Vincent
    Dupuis-Girod, Sophie
    Lesca, Gaetan
    Cordier, Jean-Francois
    [J]. RESPIRATION, 2007, 74 (04) : 361 - 378
  • [2] Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
    Dupuis-Girod, Sophie
    Ginon, Isabelle
    Saurin, Jean-Christophe
    Marion, Denis
    Guillot, Elsa
    Decullier, Evelyne
    Roux, Adeline
    Carette, Marie-France
    Gilbert-Dussardier, Brigitte
    Hatron, Pierre-Yves
    Lacombe, Pascal
    Lorcerie, Bernard
    Riviere, Sophie
    Corre, Romain
    Giraud, Sophie
    Bailly, Sabine
    Paintaud, Gilles
    Ternant, David
    Valette, Pierre-Jean
    Plauchu, Henri
    Faure, Frederic
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (09): : 948 - 955
  • [3] Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT):: Regulation of ALK-I/endoglin pathway in endothelial cells
    Fernandez-L, Africa
    Garrido-Martin, Eva M.
    Sanz-Rodriguez, Francisco
    Ramirez, Jose-Ramon
    Morales-Angulo, Carmelo
    Zarrabeitia, Roberto
    Perez-Molino, Alfonso
    Bernabeu, Carmelo
    Botella, Luisa-Mari
    [J]. THROMBOSIS AND HAEMOSTASIS, 2007, 97 (02) : 254 - 262
  • [4] Flanagan BA, 2012, CUTIS, V89, P69
  • [5] SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia
    Iyer, Nithya K.
    Burke, Carol A.
    Leach, Brandie H.
    Parambil, Joseph G.
    [J]. THORAX, 2010, 65 (08) : 745 - 746
  • [6] Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy
    Karnezis, Tom T.
    Davidson, Terence M.
    [J]. LARYNGOSCOPE, 2012, 122 (03) : 495 - 497
  • [7] Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia
    Klepfish, A
    Berrebi, A
    Schattner, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (05) : 767 - 767
  • [8] VEGF target in HHT lung patients: The role of bevacizumab as a possible alternative to embolization
    Lacout, Alexis
    Marcy, Pierre-Yves
    Thariat, Juliette
    El Hajjam, Mostafa
    Lacombe, Pascal
    [J]. MEDICAL HYPOTHESES, 2012, 78 (05) : 689 - 690
  • [9] Pancreatic Involvement in Hereditary Hemorrhagic Telangiectasia: Assessment with Multidetector Helical CT
    Lacout, Alexis
    Pelage, Jean-Pierre
    Lesur, Gilles
    Chinet, Thierry
    Beauchet, Alain
    Roume, Joelle
    Lacombe, Pascal
    [J]. RADIOLOGY, 2010, 254 (02) : 479 - 484
  • [10] Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia
    Mitchell, Andrew
    Adams, Leon A.
    Mac Uillan, Gerry
    Tibballs, Jon
    Driesen, Rohan Vanden
    Delriviere, Luc
    [J]. LIVER TRANSPLANTATION, 2008, 14 (02) : 210 - 213
12